Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive loss of dopaminergic (DAergic) neurons and low level of dopamine (DA) in the midbrain. Recent studies suggested that some natural products can protect neurons against injury, but their role on neurotransmitter release and the underlying mechanisms remained unknown. In this work, nanoelectrode electrochemistry was used for the first time to quantify DA release inside single DAergic synapses. Our results unambiguously demonstrated that harpagide, a natural product, effectively enhances synaptic DA release and restores DA release at normal levels from injured neurons in PD model. These important protective and curative effects are shown to result from the fact that harpagide efficiently inhibits the phosphorylation and aggregation of αsynuclein by alleviating the intracellular reactive oxygen level, being beneficial for vesicle loading and recycling. This establishes that harpagide offers promising avenues for preventive or therapeutic interventions against PD and other neurodegenerative disorders.
Supplementary Figures and Texts

Optimization of 6-OHDA concentration
Previous studies evidenced that 6-OHDA can induce mitochondria dysfunction via the generation of hydrogen peroxide and its derived hydroxyl radicals. DAergic neurons were incubated with increasing 6-OHDA concentrations (25 mM, 50 mM, 75 mM, 100 mM, 150 mM, and 200 mM as indicated on each view) during 4 h at 37 ℃ following they normal culture in DMEM/F12 culture medium for five days. The fluorescence intensity of the DCFH-DA probe (a ROS assay kit) reacting with ROS steadily increased upon increasing the 6-OHDA concentration used to pretreat DAergic neurons ( Figure S7a, b) . The neurotoxic effect of 6-OHDA to the neurons was further demonstrated by assessing the decreased activity of the neurons as evidenced by the Cell Counting Kit-8 (CCK-8) ( Figure S7c ). Using 6-OHDA 100 mM was found optimal for the objectives of this study since the ROS-derived fluorescence increased about 5 times of the DMEM/F12 treated group while the viability of injured neurons was about 70% of untreated neurons. 
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